 |
市場調查報告書
商品編碼
1461442
全球巴瑞特氏食道症市場，依藥物類別（質子幫浦抑制劑、H2 受體拮抗劑、黏膜保護劑等）、依配銷通路、依地理位置。Global Barretts Esophagus Market, By Drug Class (Proton Pump Inhibitors, H2 Receptor Antagonists, Mucosal Protective Agents, Others), By Distribution Channel, By Geography . |
||||||
預計2024年全球巴瑞特氏食道症市場價值為50.5億美元，預計到2031年將達到72億美元，2024年至2031年年複合成長率(CAGR)為5.2%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2023年 | 2023/2024 年市場規模： | 50.5 億美元 |
| 歷史數據： | 2019年至2023年 | 預測期： | 2024年至2031年 |
| 預測期間 2023/2024 至 2030/2031 年複合成長率： | 5.20% | 2030/2031 價值預測： | 72億美元 |
巴瑞特氏食道症是一種食道內壁因慢性胃酸逆流而受損的疾病。這是胃食道逆流 (GERD) 的嚴重併發症，食道內壁被類似腸內壁的異常組織所取代。食道細胞的這種變化會增加食道腺癌（食道癌的一種）的機會。巴瑞特氏食道症通常不會引起症狀，但可以透過食道胃十二指腸鏡檢查 (EGD) 和活體組織切片來診斷。關鍵的誘發因素是慢性胃食道逆流症，胃酸多年來會損害食道。其他危險因子包括肥胖、吸煙和男性。這種情況需要密切監測，因為它是食道癌的先兆。治療包括改變生活方式和藥物控制胃酸倒流。在某些情況下，可能會建議射頻消融或內視鏡黏膜切除術來去除發育不良的組織。
市場動態：
全球巴瑞特氏食道症市場的成長是由全球胃食道逆流症 (GERD) 盛行率和肥胖率不斷上升所推動的。慢性且未經治療的胃食道逆流症是巴瑞特氏食道症的主要危險因子。根據美國國家糖尿病、消化和腎臟疾病研究所 2020 年發布的報告，大約有 6,000 萬美國人每月至少經歷一次胃灼熱。由於腹部壓力過大，肥胖是導致胃食道逆流的另一個重要因素。市場也將從食道癌的常規篩檢實踐中受益。然而，巴瑞特氏食道症的無症狀性質可能會限制市場成長，導致某些情況下診斷不足。缺乏批准的治療藥物和高昂的管理費用也在一定程度上對市場構成課題。然而，從長遠來看，正在進行的新型診斷生物標記和治療策略的研究提供了有利可圖的機會。
研究的主要特點：
- 該報告對全球巴瑞特氏食道症市場進行了深入分析，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為基準年。
- 它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
- 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
- 它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球巴瑞特氏食道症市場的主要參與者。
- 本研究涵蓋的主要公司包括阿斯特捷利康、武田製藥有限公司、輝瑞公司、諾華國際股份公司、賽諾菲、葛蘭素史克公司、梯瓦製藥工業有限公司、雷迪博士實驗室有限公司、太陽製藥工業有限公司、 Lupin Limited、AbbVie Inc.、Ferring Pharmaceuticals、Otsuka Pharmaceutical Co., Ltd.、Taiho Pharmaceutical Co., Ltd. 和 Ono Pharmaceutical Co., Ltd.
- 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球巴雷特的食道市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
- 利害關係人可以透過用於分析全球巴瑞特氏食道症市場的各種策略矩陣輕鬆做出決策。
目錄
第1章：研究目標與假設
- 研究目標
- 假設
第 2 章：市場概述
- 報告說明
- 市場定義和範圍
- 執行摘要
第 3 章：市場動態
- 市場動態
- 促進要素
- 限制
- 機會
- 影響分析
- 害蟲分析
- 波特分析
- 技術進步
- 合併、收購和合作場景
- 最近的產品核准
- 監管場景
第 4 章：全球巴瑞特氏食道症市場，依藥物類別，2019 - 2031 年
- 介紹
- 質子幫浦抑制劑 (PPI)
- H2 受體拮抗劑
- 黏膜保護劑
- 其他（內視鏡治療藥物等）
- 市場規模及預測
第 5 章：全球巴瑞特氏食道症市場，依配銷通路分類，2019 - 2031 年
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
第 6 章：2019 - 2031 年全球巴瑞特氏食道症市場（依地區）
- 介紹
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東協
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東
- 海灣合作理事會
- 以色列
- 中東其他地區
- 非洲
- 南非
- 北非
- 中非
第 7 章：公司簡介 - 全球巴瑞特氏食道症市場
- AstraZeneca
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis International AG
- Sanofi
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- AbbVie Inc.
- Ferring Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
第 8 章：參考文獻與研究方法
- 參考
- 研究方法論
Global Barrett's esophagus market is estimated to be valued at USD 5.05 Bn in 2024 and is expected to reach USD 7.20 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 5.05 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 5.20% | 2030/2031 Value Projection: | US$ 7.20 Bn |
Barrett's esophagus is a condition where the lining of the esophagus is damaged due to chronic acid reflux. It is a serious complication of gastroesophageal reflux disease (GERD) where the lining of the esophagus is replaced by the abnormal tissue similar to the lining of the intestine. This change in the cells of the esophagus can increase the chances of developing esophageal adenocarcinoma, a type of esophageal cancer. Barrett's esophagus usually does not cause symptoms but can be diagnosed by esophagogastroduodenoscopy (EGD) along with biopsy. The key predisposing factor is chronic GERD where stomach acid damages the esophagus over many years. Other risk factors include obesity, smoking, and male gender. The condition needs to be closely monitored as it is a precursor to esophageal cancer. Treatment involves lifestyle modifications and medication to control acid reflux. In some cases, radiofrequency ablation or endoscopic mucosal resection may be recommended to remove dysplastic tissues.
Market Dynamics:
Global Barrett's esophagus market growth is driven by increasing prevalence of gastroesophageal reflux disease (GERD) and obesity rates worldwide. Chronic and untreated GERD are major risk factors for Barrett's esophagus. According to the National Institute of Diabetes and Digestive and Kidney Diseases Report published in 2020, approximately 60 million Americans experience heartburn at least once a month. Obesity is another important factor predisposing to GERD due to excess pressure on the abdomen. The market also stands to benefit from routine screening practices for esophageal cancer. However, the market growth can be restrained by the asymptomatic nature of Barrett's esophagus leading to underdiagnoses in some cases. Lack of approved drugs for the treatment and high cost of management procedures also challenges the market to some extent. Nevertheless, ongoing research on novel diagnostic biomarkers and therapeutic strategies present lucrative opportunities in the long run.
Key Features of the Study:
- This report provides an in-depth analysis of the global Barrett's esophagus market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Barrett's esophagus market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include AstraZeneca, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis International AG, Sanofi, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, AbbVie Inc., Ferring Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Barrett's esophagus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Barrett's esophagus market
Detailed Segmentation:
- By Drug Class:
- Proton Pump Inhibitors (PPIs)
- H2 Receptor Antagonists
- Mucosal Protective Agents
- Others (Endoscopic Therapy Drugs, etc.)
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- AstraZeneca
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis International AG
- Sanofi
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- AbbVie Inc.
- Ferring Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
- Market Opportunity Map
3. Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancement
- Merger, Acquisition and Collaboration Scenario
- Recent Product Approvals
- Regulatory Scenario
4. Global Barrett's Esophagus Market, By Drug Class, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
- Proton Pump Inhibitors (PPIs), 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- H2 Receptor Antagonists, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Mucosal Protective Agents, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others (Endoscopic Therapy Drugs, etc.), 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
5. Global Barrett's Esophagus Market, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
- Hospital Pharmacies, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Retail Pharmacies, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Online Pharmacies, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
6. Global Barrett's Esophagus Market, By Region, 2019 - 2031, (US$ Billion)
- Introduction
- Market Share Analysis, 2024 - 2031, (US$ Billion)
- Segment Trends
- By Region
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- GCC
- Israel
- Rest of The Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
- South Africa
- North Africa
- Central Africa
7. Company Profiles - Global Barrett's Esophagus Market
- AstraZeneca*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis International AG
- Sanofi
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- AbbVie Inc.
- Ferring Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
8. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
